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The rate of orthodontic tooth movement is affected by individual 
variations in tissue reactions, by the type of force applied, and by the 
mechanical principles involved. Practitioners have been using light force and 
frictionless appliances, as well as hormones, electricity, and magnetic force, to 
enhance the rate of orthodontic tooth movement.
60
 Nonetheless, mechanical 
forces have been the most preferred and widely used choice by most 
contemporary clinicians. Forces exerted by mechanical means however, are 
exceedingly variable and the clinical response to its application remains 
unpredictable. This phenomenon has been demonstrated in laboratory 
animals,
45
 as well as in patients, in whom teeth treated with similar 
orthodontic appliances have been shown to move at different rates.
57
 Since the 
rate of tooth movement is intimately associated with bone remodeling 
activities, a better understanding of specific biochemical pathways in 
individual patients may provide the key to predicting how teeth will respond to 
mechanical force. This knowledge, in turn, can lead to the enhancement of 
tooth movement. 
Orthodontic tooth movement results from remodeling of the 
periodontal ligament and alveolar bone. Mechanical stress from orthodontic 
appliances is considered to induce cells in the PDL to form biologically active 
  
substances, such as prostaglandin E, interleukin (IL)-1b, IL-6, tumor necrosis 
factor (TNF)-a, and epidermal growth factor (EGF) which are responsible for 
connective tissue remodeling.
12
 These factors contribute to bone remodeling, 
which is a dynamic interaction between bone-forming osteoblasts and bone-
resorbing osteoclasts. The rate of remodeling is defined primarily by cells of 
the osteoblast lineage, which, in addition to bone formation, are also 
responsible for the activation and recruitment of osteoclast precursors.
 
 
 Recently, an intermediary factor, receptor activator of nuclear factor 
κB ligand (RANKL), presenting on the surface of osteoblasts was found to be 
responsible for the induction of osteoclastogenesis.
87
 Binding of RANKL to its 
cognate receptor, receptor activator of nuclear factor κB (RANK), expressed 
on the surface of osteoclast progenitor cells, induces osteoclastogenesis and 
activates osteoclasts, resulting in increased bone resorption. 
47 
On the other hand, RANKL has a capability to bind to osteoprotegerin 
(OPG), which is also a member of the tumor necrosis factor (TNF) receptor 
family. OPG is a soluble decoy receptor protein that competitively binds to 
cell surface membrane-bound RANKL proteins and inhibits RANKL 
activation of osteoclastogenesis.
77
 OPG is produced by human periodontal 
ligament cells, gingival fibroblasts, human pulp cells, and epithelial cells and 
has been found to be a key factor in the inhibition of osteoclast differentiation 
and activation.
28   
  
Although there some are contradictory data, in general when RANKL 
expression is up-regulated, OPG expression is down-regulated or not induced 
to the same degree as RANKL, such that the RANKL/OPG ratio changes in 
favor of osteoclastogenesis.
34,76
 Osteoclast numbers and activity can increase 
if there is a change in the RANKL/OPG ratio due to either an increase in the 
former or a decrease in the latter or a change in both that leads to a change in 
the ratio in favor of RANKL. 
At the cellular and molecular levels, tooth movement is the result of 
the interaction between bone-forming osteoblasts and bone-resorbing 
osteoclasts. Given the critical role osteoclasts play in tooth movement, it 
follows that the RANK/RANKL/OPG pathway is likely to be critical in this 
process. Indeed, it has been shown that application of orthodontic forces 
results in the expression of RANKL protein in osteoblasts, osteocytes, 
fibroblasts, and osteoclasts.
88 
During orthodontic tooth movement, RANKL expression is induced on 
the compressed side of the tooth.
54,65 
 In contrast, on the tensile side of the 
tooth, there is an increase in OPG synthesis.
38,78
 The relative expressions of 
OPG and RANKL on the tensile and compressed sides of the tooth during 
orthodontic tooth movement regulate bone remodeling. Orthodontic forces 
induce the movement of PDL fluids and, with them, any cellular biochemical 
product produced from prior mechanical perturbation. The direction of flow of 
the PDL fluid may be as follows: from an area of compression, to an area of 
  
tension, both apically and coronally, towards the gingival sulcus, and/or into 
the alveolar marrow spaces. Therefore, compression of the PDL should cause 
cellular biochemical by-products to appear in the sulcus.
88 
As a result of the application of mechanical forces, PDL cells may 
produce sufficient amount of modulators during bone remodeling to diffuse 
into the gingival crevicular fluid (GCF). These substances can be monitored 
non-invasively in humans by following changes in the composition of the 
GCF during orthodontic tooth movement.
22 
Clinical studies have confirmed 
that both RANKL and OPG can be detected in human gingival crevicular fluid 
(GCF) and indicate that RANKL is elevated whereas OPG is decreased in 
periodontitis. 
42,72 
This phenomenon opens up an entire new vista, and with adequate 
scientific research could prove to be an important new biologic marker for 
tooth movement. Although it has been amply proven that the RANKL and 
OPG play critical roles in bone remodeling and during bone resorptive 
conditions like periodontitis, little information is available concerning the 
production of these modulators during orthodontic tooth movement in human 
subjects.
33,50 
The available literature focuses primarily on an Oriental 




Keeping this in mind, the aim of this study was to assess the level of 
OPG and RANKL in the gingival crevicular fluid during orthodontic treatment 
at two different time points in an Indian population. 
Results of this study could help us determine an optimum ratio of 
RANKL/OPG in the GCF of patients undergoing orthodontic tooth movement 
 The clinical implications of this study are far fetched at this stage, as 
the tests to evaluate the concentrations of these proteins are currently available 
only in a research setting. Further research in this field could see a refinement 
in these tests making them suitable for diagnostic use in a clinical setting. This 
would enable periodic monitoring of the levels of these cytokines in the GCF 
of orthodontic patients.  This sort of assessment would give the orthodontist an 
insight into the epigenetic factors affecting tooth movement which cannot be 
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REVIEW OF LITERATURE 
 
The role of RANK/RANKL/OPG in bone remodeling 
 Shalhoub V, Faust J, Boyle WJ, Dunstan CR, Kelley M, Kaufman 
S, Scully S, Van G, Lacey DL(1999)
63
 demonstrated the effects of soluble 
OPGL and OPG on the developing human osteoclast phenotype, on bone 
slices, using peripheral blood mononuclear cells (PBMCs), cultured for 2 
weeks, without stromal cells. They found that OPGL (2-50 ng/ml), increased 
the size of osteoclast-like cells on bone, as defined by the acquisition of 
osteoclast markers: vitronectin receptor (VR), tartrate-resistant acid 
phosphatase (TRAP), multinuclearity, and bone resorption. By 14 days, with 
20 ng/ml OPGL, the largest cells/10x field had achieved an average diameter 
of 163+/-38 microm, but only approximately 10-20 microm in its absence and 
the number of osteoclast-like cells/mm2 bone surface was about 128. By 
scanning electron microscopy, OPGL-treated (20-ng/ml) cultures contained 
small osteoclast-like cells on bone with ruffled "apical" surfaces by day 7; by 
day 15, large osteoclast-like cells were spread over resorption lacunae. At 15 
ng/ml OPGL, about 37% of the bone slice area was found to be covered by 
resorption lacunae. This study confirms a pivotal role for OPGL and OPG in 
the modulation of human osteoclast differentiation and function. 
  
 Takahashi N, Udagawa N, Suda T. (1999)
70
 showed that 
osteoblasts/stromal cells express a member of the TNF-ligand family 
"osteoclast differentiation factor(ODF)/osteoprotegerin ligand (OPGL)/TNF-
related activation-induced cytokine (TRANCE)/receptor activator of NF-kB 
ligand (RANKL)" as a membrane associated factor. Osteoclast precursors 
which possess RANK, a TNF receptor family member, recognize 
ODF/OPGL/TRANCE/RANKL through cell-to-cell interaction with 
osteoblasts/stromal cells, and differentiate into osteoclasts in the presence of 
macrophage colony-stimulating factor. Mature osteoclasts also express 
RANK, and their bone-resorbing activity is also induced by 
ODF/OPGL/TRANCE/RANKL which osteoblasts/stromal cells possess. 
Osteoprotegerin (OPG)/osteoclastogenesis inhibitory factor (OCIF)/TNF 
receptor-like molecule 1 (TR1) is a soluble decoy receptor for 
ODF/OPGL/TRANCE/RANKL. They found that activation of NF-kB through 
the RANK-mediated signaling system appears to be involved in differentiation 
and activation of osteoclasts. 
 Hailing Hsu, David Lacey, Colin r. Dunstan, Irina Solovyev, Anne 
Colombero, Emma Timms, Hong-lin Tan, Gary Elliott, Michael J. Kelley, 
Ildiko Sarosi, Ling wang, Xing-zhong Xia, Robin Elliott, Laura Chiu, 
Tabitha Black, Sheila Scully, Casey Capparelli, Sean Morony, Grant 
Shimamoto, Michael Bass, and William Boyle (1999)
25
 took the genomic 
approach to examine genes expressed in murine osteoclast precursors. They 
  
described the identification and characterization of the osteoclast 
differentiation and activation receptor that is present on normal mouse 
osteoclast progenitors and which mediates OPGL-induced osteoclast 
differentiation and activation. The identified receptor is indeed identical to the  
TNFR family member RANK. Like several known TNFR family members, 
the signaling pathway of RANK involves the interaction with cytoplasmic 
TNFR-associated factor (TRAF) proteins. Cumulatively, their findings reveal 
that OPGL–RANK–OPG comprise key regulatory proteins that govern 
osteoclast development. 
 Teresa L. Burgess, Yi-xin Qian, Stephen Kaufman, Brian D. Ring, 
Gwyneth Van, Charles Capparelli, Michael Kelley, Hailing Hsu, William J. 
Boyle, Colin R. Dunstan, Sylvia Hu, and David L. Lacey (1999)
75
 using 
primary cultures of rat osteoclasts on bone slices, found that OPGL causes 
approximately sevenfold increase in total bone surface erosion. By scanning 
electron microscopy, it was found that OPGL-treated osteoclasts generate 
more clusters of lacunae on bone suggesting that multiple, spatially associated 
cycles of resorption have occurred. However, the size of the individual 
resorption events are unchanged by OPGL treatment. Mechanistically, OPGL 
binds specifically to mature OCs and rapidly (within 30 min) induces actin 
ring formation; a marked cytoskeletal rearrangement that necessarily precedes 
bone resorption. Furthermore, they also showed that antibodies raised against 
the OPGL receptor, RANK, also induce actin ring formation. OPGL treated 
  
mice exhibit increases in blood ionized Ca
++
 within 1 h after injections, 
consistent with immediate OC activation in vivo. 
 Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. 
(1999)
68
 showed that osteoclast precursors express RANK, a TNF receptor 
family member, recognize RANKL through cell-to-cell interaction with 
osteoblasts/stromal cells, and differentiate into osteoclasts in the presence of 
M-CSF.  
Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony 
S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran 
E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle 
WJ, Penninger JM. (1999)
36
 showed that bone remodelling and bone loss are 
controlled by a balance between the tumour necrosis factor family molecule 
osteoprotegerin ligand (OPGL) and its decoy receptor osteoprotegerin (OPG). 
They reported that activated T cells can directly trigger osteoclastogenesis 
through OPGL. Systemic activation of T cells in vivo leads to an OPGL-
mediated increase in osteoclastogenesis and bone loss. They demonstrated that 
in a T-cell-dependent model of rat adjuvant arthritis characterized by severe 
joint inflammation, bone and cartilage destruction and crippling, blocking of 
OPGL through osteoprotegerin treatment at the onset of disease prevents bone 
and cartilage destruction but not inflammation. These results show that both 
systemic and local T-cell activation can lead to OPGL production and 
subsequent bone loss.    
  
H. Kanzaki, M. Chiba, Y. Shimizu, and H. Mitani (2001)
23
 examined 
the consequences of cell-to cell interactions between peripheral blood 
mononuclear cells (PBMCs) and PDL cells during osteoclastogenesis. 
indirectly with PDL cells for two to four weeks. PBMCs that were directly co-
cultured with PDL cells formed significantly more resorption pits on dentin 
slices than did PBMCs that were cultured alone. PDL cells expressed both 
RANKL and OPG mRNA. They concluded that PDL cells support 
osteoclastogenesis through cell to- cell contact. PDL cells might regulate 
osteoclastogenesis by opposing mechanisms: stimulation of resorptive activity 
by RANKL and inhibition by OPG thus affecting processes such as 
periodontitis and orthodontic tooth movement. 
Shimizu-Ishiura M, Kawana F, Sasaki T (2002)
64
 examined the 
effects of OPG administration on the distribution, ultrastructure and vacuolar-
type H+-ATPase expression of osteoclasts and resulting trabecular bone loss 
in the femurs of ovariectomized (OVX) mice. Two-month-old female mice 
were allocated to the following groups: (1) pretreatment base-line controls; (2) 
untreated sham-operated controls; (3) untreated OVX; and (4) OPG-
administered OVX mice. Postoperatively, OPG (0.3 mg kg(-1) day(-1)) was 
intraperitoneally administered daily to OVX mice for 7 days. On postoperative 
day 7, all mice were sacrificed, and the dissected femurs were examined by 
means of light and immunoelectron microscopy and quantitative 
backscattered-electron image analysis. Backscattered-electron examination 
  
revealed that trabecular bone area/unit medullary area in untreated OVX mice 
was significantly lower than that of base-line control and sham-operated 
control mice. Compared with untreated OVX mice, OPG administration to 
OVX mice significantly increased trabecular bone area, which was similar to 
that of sham-operated control mice. Surprisingly, the number of TRAP-
positive osteoclasts along the trabecular bone surfaces in OPG-administered 
OVX mice was not significantly decreased compared with that of sham-
operated control and untreated OVX mice. Ultrastructurally, OPG 
administration caused disappearance of ruffled borders in most osteoclasts, but 
induced neither necrotic nor apoptotic changes. In addition, the expression of 
vacuolar-type H+-ATPase in osteoclasts was decreased by OPG 
administration. Their results suggest that low-dose OPG administration 
significantly reduces trabecular bone loss in OVX mice via impairment of the 
structure and bone resorbing activity of osteoclasts. 
Sasaki T (2003)
62
 in an examination of preosteoclast (pOC) culture 
demonstrated that RANKL and OPG are important regulators of not only the 
terminal differentiation of OC but also their resorptive function. The study 
showed pOCs formed without any additives expressed tartrate-resistant acid 
phosphatase (TRAP), but showed little resorptive activity. pOC treated with 
RANKL became TRAP-positive OC, which expressed intense vacuolar-type 
H(+)-ATPase and exhibited prominent resorptive activity. Such effects of 
RANKL on pOC were completely inhibited by addition of OPG. OPG 
  
inhibited ruffled border formation in mature OC and reduced their resorptive 
activity, and also induced apoptosis of some OC. Although OPG 
administration significantly reduced trabecular bone loss in the femurs of 
ovariectomized (OVX) mice, the number of TRAP-positive OC in OPG-
administered OVX mice was not significantly decreased. Rather, OPG 
administration caused the disappearance of ruffled borders and decreased 
H(+)-ATPase expression in most OC. OPG deficiency causes severe 
osteoporosis. RANKL localization and OC induction in periodontal ligament 
(PDL) during experimental movement of incisors in OPG-deficient mice was 
also examined. Compared to wild-type OPG (+/+) littermates, after force 
application, TRAP-positive OC were markedly increased in the PDL and 
alveolar bone was severely destroyed in OPG-deficient mice. In both wild-
type and OPG-deficient mice, RANKL expression in osteoblasts and 
fibroblasts became stronger by force application. These in vitro and in vivo 
studies suggest that RANKL and OPG are important regulators of not only the 
terminal differentiation of OC but also their resorptive function. Lastly, he 
examined the expression of H(+)-ATPase, cathepsin K, and matrix 
metalloproteinase-9 in odontoclasts (OdC) during physiological root 
resorption in human deciduous teeth, and found that there were no differences 
in the expression of these molecules between OC and OdC. RANKL was also 
detected in stromal cells located on resorbing dentine surfaces. This suggests 
that there is a common mechanism in cellular resorption of mineralized tissues 
such as bone and teeth. 
  
Yamazaki H, Sasaki T (2005)
86
 using OPG-deficient mice, attempted 
to clarify the differentiation and ultrastructure of osteoclasts located on the 
destroyed growth plate cartilage and trabecular bone matrix in long bones. In 
(-/-) homozygous OPG knockout mice, adjacent to the growth plate cartilage, 
the formation of bone trabeculae without a calcified cartilaginous core resulted 
in an irregular chondrocyte distribution in the growth plate cartilage. At the 
metaphyseal ossification center, TRAP-positive osteoclasts showed unusual 
localization on both type-II collagen-positive cartilage and type-I collagen-
positive bone matrix. Osteoclasts located on cartilage matrix lacked a typical 
ruffled border structure, but formed resorption lacunae. During growth plate 
cartilage destruction, osteoclasts formed ruffled border structures on bone 
matrix deposited on the remaining cartilage surfaces. These findings suggest 
that, in OPG (-/-) mice, osteoclast structure differs, depending on the matrix of 
either cartilage or bone. Then, they examined the effects of OPG 
administration on the internal trabecular bone structure and osteoclast 
differentiation in OPG (-/-) mice. OPG administration to OPG (-/-) mice 
significantly inhibited trabecular bone loss and maintained the internal 
trabecular bone structure, but did not reduce the osteoclast number on bone 
trabeculae. For most osteoclasts, OPG administration caused disappearance or 
reduction of the ruffled border, but induced neither necrotic nor apoptotic 
damages. These results suggest that OPG administration is an effective means 
of maintaining the internal structure and volume of trabecular bone in 
metabolic bone diseases by inhibition of osteoclastic bone resorption. 
  
Baud'huin M, Duplomb L, Ruiz Velasco C, Fortun Y, Heymann 
D, Padrines M (2007)
6 
showed that any dysregulation of their respective 
expression of RANKL/OPG leads to pathological conditions. Furthermore, 
they also demonstrated that the OPG-RANK-RANKL system modulates 
cancer cell migration, thus controlling the development of bone metastases. 
Ominsky MS, Kostenuik PJ, Cranmer P, Smith SY, Atkinson JE 
(2007)
52
 investigated the safety and pharmacology of the RANKL inhibitor 
OPG-Fc in gonad-intact cynomolgus monkeys. Cortical and trabecular 
volumetric BMD and BMC, cortical thickness, and cross-sectional moment of 
inertia were significantly increased by OPG-Fc treatment at the proximal tibia 
and distal radius metaphyses. Increases in cortical thickness were associated 
with significantly greater periosteal circumference. They inferred that OPG-Fc 
increased cortical and trabecular BMD and BMC in young gonad-intact 
cynomolgus monkeys. 
 Brendan F. Boyce, and Lianping Xing (2008)
9
 demonstrated that 
hypertrophic and to a lesser extent prehypertrophic chondrocytes express 
RANKL, OPG and RANK. Mice deficient in RANKL, RANK and NF-κB p50 
and p52 develop osteopetrosis because they do not form osteoclasts and have 
thickened hypertrophic cartilage zones in their growth plates. This defect is 
rectified spontaneously between 2 and 3 weeks of age in the RANKL−/− and 
RANK−/− mice and 2–3 weeks later in the NF-κB p50 and p52 double 
  
knockout mice. The precise role of RANKL/RANK/NF-κB signaling in 
chondrocytes during endochondral ossification remains poorly understood, but 
these findings suggest that it may regulate the lifespan of hypertrophic 
chondrocytes through NF-κB p50 and p52-regulated genes at least 
temporarily, similar to MMP-9 (11), which is regulated by NF-κB. All of these 
knockout mice are dwarfed, suggesting that RANKL/RANK/NF-κB signaling 
during the first 2–3 weeks of life is essential for attainment of full skeletal 
growth 
 Ominsky MS, Li X, Asuncion FJ, Barrero M, Warmington 
KS, Dwyer D, Stolina M, Geng Z, Grisanti M, Tan HL, Corbin T, McCabe 
J, Simonet WS, Ke HZ, Kostenuik PJ. (2008)
53
 examined whether the 
RANKL inhibitor osteoprotegerin (OPG) would preserve bone volume, 
density, and strength in ovariectomized (OVX) rats. OVX was associated with 
significantly greater serum RANKL. They found that OPG markedly reduced 
osteoclast surface and serum TRACP5b while completely preventing OVX-
associated bone loss in the lumbar vertebrae, distal femur, and femur neck. 
Vertebrae from OPG-treated rats had increased dry and ash weight, with no 
significant differences in tissue mineralization versus OVX controls.  Bone 
strength was also significantly increased by OPG. 
 
  
 Stolina M, Schett G, Dwyer D, Vonderfecht S, Middleton S, Duryea 
D, Pacheco E, Van G, Bolon B, Feige U, Zack D, Kostenuik P (2009)
67 
demonstrated that RANKL inhibition prevented local and systemic bone loss 
without significantly inhibiting local or systemic inflammatory parameters. 
Lewis rats with established rat adjuvant-induced arthritis (AIA) or collagen-
induced arthritis (CIA) were treated for 10 days (from day 4 post onset) with 
RANKL inhibitor (osteoprotegerin (OPG)-Fc). Local inflammation was 
evaluated by monitoring hind paw swelling. Bone mineral density (BMD) of 
paws and lumbar vertebrae was assessed by dual X-ray absorptiometry. OPG-
Fc reduced BMD loss in ankles and vertebrae in both models, but had no 
effect on paw swelling. They found that RANKL inhibition by OPG-Fc did 
not lessen systemic cytokine levels in either model but prevented local and 
systemic bone loss. 
Bastos MF, Brilhante FV, Gonçalves TE, Pires AG, Napimoga 
MH, Marques MR, Duarte PM.(2010)
4
 evaluated the ligature-induced bone 
loss (BL) and quality of tooth-supporting alveolar bone in spontaneously 
hypertensive rats (SHRs) by histometric, histochemical, and 
immunohistochemical analyses. They found a decreased expression of 
RANKL in the treated SHR group. They concluded that SHRs present harmful 
alterations in the quality of tooth-supporting bone and attributed this to the 
decreased the expression of bone-resorption markers. 
  
The relation between RANK/RANKL/OPG and Periodontal disease 
development 
T Nagasawa, H Kobayashi, M Kiji, M Aramaki, R Mahanonda,  
T Kojima, Y Murakami, M Saito, Y Morotome, and I Ishikawa (2002)
69
 
examined the expression of RANKL and its inhibitor, osteoprotegerin (OPG), 
in inflamed gingival tissue and attempted to clarify the role of human gingival 
fibroblasts (HGFs) in osteoclastogenesis regulated by RANKL. HGFs and 
gingival mononuclear cells (GMCs) were obtained from chronic periodontitis 
patients during routine periodontal surgery. Expression of OPG and RANKL 
mRNA in gingival tissue and HGFs was examined with RT-PCR. OPG 
production was measured using ELISA. Expression of RANKL, CD4, CD8 
and CD69 on GMCs was determined by flow-cytometry using RANK-Fc 
fusion protein and the respective monoclonal antibodies. Osteoclastogenesis 
by RANKL was assayed by counting the number of tartarate-resistant acid 
phosphatase (TRAP)-positive cells after culturing human peripheral blood 
monocytes with recombinant human RANKL and macrophage-colony 
stimulating factor (M-CSF) for 10 days. OPG and RANKL mRNA were 
expressed in 80% (16/20) and 25% (5/20) of periodontitis lesions, 
respectively. OPG, but not RANKL, mRNA was expressed within HGFs. 
OPG mRNA expression and production by HGFs was augmented by LPS 
stimulation. All GMC samples expressed CD69, and two of five GMC 
samples expressed RANKL. The culture supernatant of LPS-stimulated 
  
gingival fibroblasts significantly reduced the number of TRAP positive cells 
generated by culturing monocytes with RANKL and M-CSF. The present 
study suggests that LPS-stimulated HGFs inhibit monocyte differentiation into 
osteoclasts through the production of OPG. 
Liu D, Xu JK, Figliomeni L, Huang L, Pavlos NJ, Rogers M, Tan A, 
Price P, Zheng MH (2003)
40
 used semi-quantitative RT-PCR to compare the 
gene expression of RANKL and OPG, between moderate and advanced 
periodontitis, and healthy subjects. The level of RANKL mRNA was highest 
in advanced periodontitis. In contrast, the level of OPG mRNA in both 
advanced and moderate periodontitis was lower than that in the healthy group. 
They demonstrated an increased ratio of RANKL to OPG mRNA in 
periodontitis. In situ hybridization was performed to localize RANKL mRNA 
and it was found to be expressed in inflammatory cells, mainly lymphocyte 
and macrophages. In addition, proliferating epithelium in the vicinity of 
inflammatory cells expressed high levels of RANKL mRNA.Their data 
suggest that up regulation of RANKL mRNA in both inflammatory cells and 
epithelium may be associated with the activation of osteoclastic bone 
destruction in periodontitis. 
Tania Crotti, Malcolm D. Smith, Robert Hirsch, Steven 
Soukoulis, Helen Weedon, Maria Capone, Michael J. Ahern, David Haynes 
(2003)
72
 compared the levels of the RANKL and OPG in the granulomatous 
tissue adjacent to areas of alveolar bone loss from patients with periodontitis 
  
to that present in tissue from patients without periodontitis. Semiquantitative 
image analysis demonstrated that significantly higher levels of RANKL 
protein were expressed in the periodontitis tissue. Conversely, OPG protein 
was significantly lower in the periodontitis tissues. RANKL protein was 
associated with lymphocytes and macrophages. OPG protein was associated 
with endothelial cells in both tissues. 
M. Mogi, J. Otogoto, N. Ota, and A. Togari (2004)
42
 reported the in 
vivo concentrations of RANKL and the RANKL decoy receptor 
osteoprotegerin (OPG) in the gingival crevicular fluid (GCF) of periodontal 
subjects with severe, moderate, and mild forms of the disease. An increased 
concentration of RANKL and a decreased concentration of OPG were detected 
in GCF from patients with periodontitis (p < 0.05 vs. control subjects). The 
ratio of the concentration of RANKL to that of OPG in the GCF was 
significantly higher for periodontal disease patients than for healthy subjects 
(p < 0.01). These data suggest that RANKL and OPG contribute to 
osteoclastic bone destruction in periodontal disease. 
Garlet GP, Martins W Jr, Fonseca BA, Ferreira BR, Silva JS 
(2004)
19
 investigated the expression of matrix metalloproteinases (MMPs) and 
the osteoclastogenic factor receptor activator of nuclear factor-kappaB ligand 
(RANKL), their respective tissue inhibitors of metalloproteinases (TIMPs) and 
osteoprotegerin (OPG) in different forms of human periodontal diseases 
(PDs), and the possible correlation with the expression of inflammatory and 
  
regulatory cytokines. Quantitative polymerase chain reaction (real-time PCR) 
was performed with gingival biopsies mRNA from aggressive (AP) and 
chronic periodontitis (CP) patients. They found that patients with periodontitis 
exhibited higher expression of all analyzed factors when compared with 
healthy tissues. The expression of MMPs and RANKL were similar in AP and 
CP, as well as the expression of TNF-alpha. On the other hand, the expression 
of TIMPs and OPG was higher in CP, and was associated with lower IFN-
gamma and higher IL-10 expression, compared with AP. They thus concluded 
that the pattern of cytokines expressed determines the stable or progressive 
nature of the lesions and regulates the severity of PD, driving the balance 
between MMPs and TIMPs, RANKL and OPG expression in the gingival 
tissues controlling the breakdown of soft and bone tissues and, consequently, 
the disease severity. 
Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela 
MA, Gamonal J.(2004)
81
 demontrated that RANKL was found in a higher 
proportion (85%) of samples from patients than from controls (46%). The total 
amount of RANKL was significantly higher in patients (115.53 +/- 78.18 
picograms/ml) than in healthy subjects (63.08 +/- 55.08 pg/ml). Active sites, 
presumably associated with tissue destruction, had significantly higher levels 
of RANKL than their inactive counterparts (125.95 pg/ml versus 91.80 pg/ml) 
 
  
Garlet, G. P., Cardoso, C. R., Silva, T. A., Ferreira, B. R., Ávila-
Campos, M. J., Cunha, F. Q. and Silva, J. S. (2006)
20
, investigated the 
expression of matrix metalloproteinases (MMPs) and the osteoclastogenic 
factor RANKL (receptor activator of nuclear factor-κB ligand), their 
respective inhibitors TIMPs (tissue inhibitors of metalloproteinases) and OPG 
(osteoprotegerin) and their possible correlation with the expression of 
inflammatory and regulatory cytokines in the course of experimental 
periodontal disease in mice. Their data demonstrates two distinct patterns of 
MMP/TIMP and RANKL/OPG expression in the course of experimental 
periodontal disease. The expression of MMPs (MMP-1, 2 and 9) and RANKL 
was correlated with the expression of interleukin-1β, tumor necrosis factor-  
and interferon- , in a time period characterized by the intense increase of 
inflammatory reaction and alveolar bone loss. On the other hand, interleukin-4 
and interleukin-10 were associated with higher expression of TIMPs (TIMP 1, 
2 and 3) and OPG, with a lower expression of MMPs and RANKL, and with 
reduced rates of increase of cellular infiltration in periodontal tissues and 
alveolar bone loss. They inferred that the pattern of cytokines produced in 
periodontal tissues determines the progression and the severity of 
experimental periodontal disease, controlling the breakdown of soft and bone 
tissues through the balance between MMPs/TIMP and RANKL/OPG 
expression in gingival tissues. 
 
  
Lu HK, Chen YL, Chang HC, Li CL, Kuo MY (2006)
41
 carried out a 
study to quantify OPG/RANKL in the gingival crevicular fluid (GCF) and 
connective tissue of patients with periodontitis, and to clarify possible 
correlations with disease severity. They found that GCF RANKL, but not 
OPG, was elevated in diseased sites of patients with periodontitis. However, 
the expressions of OPG and RANKL showed no correlation with disease 
severity. Immunohistochemical staining showed that RANKL-positive cells 
were significantly distributed in the inflammatory connective tissue zone of 
diseased gingiva, compared with those of samples from non-diseased persons. 
Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, 
Karimbux NY, Goncalves RB, Valverde P, Dibart S, Li YP, Miranda LA, 
Ernst CW, Izumi Y, Taubman MA. (2006)
32
 conducted a studyto identify the 
cellular source of RANKL in the bone resorptive lesions of periodontal 
disease. The concentrations of soluble RANKL, but not its decoy receptor 
osteoprotegerin, measured in diseased tissue homogenates were found to be 
significantly higher in diseased gingival tissues than in healthy tissues. 
Double-color confocal microscopic analyses demonstrated less than 20% of 
both B cells and T cells expressing RANKL in healthy gingival tissues. By 
contrast, in the abundant mononuclear cells composed of 45% T cells, 50% B 
cells, and 5% monocytes in diseased gingival tissues, more than 50 and 90% 
of T cells and B cells, respectively, expressed RANKL. RANKL production 
by nonlymphoid cells was not distinctly identified. Lymphocytes isolated from 
  
gingival tissues of patients induced differentiation of mature osteoclast cells in 
a RANKL-dependent manner in vitro. However, similarly isolated peripheral 
blood B and T cells did not induce osteoclast differentiation, unless they were 
activated in vitro to express RANKL; emphasizing the osteoclastogenic 
potential of activated RANKL-expressing lymphocytes in periodontal disease 
tissue. These results suggest that activated T and B cells can be the cellular 
source of RANKL for bone resorption in periodontal diseased gingival tissue. 
Rolando Vernal, Nicolás Dutzan, Marcela Hernández, Sabrita 
Chandía, Javier Puente, Rubén León, Leyre García, Ignacio Del Valle, 
Augusto Silva and Jorge Gamonal (2006)
59
 demonstrated that gingival 
CD4(+) T cells are the main cells responsible for higher levels of RANKL 
observed in human chronic periodontitis patients. Gingival biopsies were 
obtained from 33 chronic periodontitis patients and 20 healthy controls. 
RANKL mRNA and protein levels were determined by quantitative RT-PCR 
and enzyme-linked immunosorbent assay (ELISA) in gingival-cell culture 
supernatants. Gingival leukocytes were quantified by flow cytometry. RANKL 
and CD4 immunoreactivity were analyzed by flow cytometry and confocal 
microscopy. They found that RANKL mRNA levels were higher in patients 
with periodontitis than in healthy subjects, and spontaneous and 
lipopolysaccharide (LPS)- and phytohemagglutinin (PHA)-stimulated 
RANKL synthesis were higher also in patients than controls. CD4(+) T 
lymphocytes were the predominant infiltrate cell subset present in gingival 
  
tissues of periodontitis patients. Furthermore, an association between RANKL 
and CD4(+) T cells was determined by double-staining flow cytometry and 
confocal microscopy.  
N. Bostanci, T. Ilgenli, G. Emingil, B. Afacan, B. Han, G. Atilla, F.J. 
Hughes, and G.N. Belibasakis (2007)
46
 compared the concentrations of 
RANKL, OPG and their relative ratio in gingival crevicular fluid (GCF) of 
patients with periodontal disease. They found that there was no significant 
difference in RANKL and OPG levels between chronic and generalized 
aggressive periodontitis groups. The RANKL/OPG ratio was elevated by 
approximately 200 fold in both chronic periodontitis and generalized 
aggressive periodontitis, compared to healthy patients. This increase in ratio in 
both forms of periodontitis, may be a key factor in determining attachment 
loss in periodontitis. 
Wara-aswapati N, Surarit R, Chayasadom A, Boch JA, Pitiphat W 
(2007)
82
 showed for the first time to an association between upregulated 
RANKL levels and the number of P. gingivalis in clinically obtained 
periodontal tissues. They studied the expression of RANKL and OPG mRNA 
and the relationship between these factors and periodontopathic bacteria in 
periodontal tissue. Gingival tissue and subgingival plaque samples were 
collected from 15 patients with chronic periodontitis and 15 periodontally 
healthy subjects. RNA, extracted from the tissue was subjected to reverse 
  
transcription-polymerase chain reaction (RT-PCR) using primers specific for 
RANKL or OPG. Their results showed increased levels of RANKL mRNA in 
chronic periodontitis tissues. The RANKL/OPG expression ratio was 
significantly higher in the periodontitis group compared to the healthy control 
group (P = 0.001). Also, the expression of RANKL (P <0.001), but not OPG 
(P = 0.20), was significantly correlated with increased numbers of P. 
gingivalis.  
Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Töz H, Berdeli 
A, Atilla G, McKay IJ, Hughes FJ, Belibasakis GN (2007)
7
 demonstrated 
that RANKL and osteoprotegerin expression are differentially regulated in 
various forms of periodontitis, and the relative RANKL/osteoprotegerin ratio 
appears to be indicative of disease occurrence. Gingival tissue was obtained 
from nine healthy subjects and 41 patients, who had gingivitis, chronic 
periodontitis, generalized aggressive periodontitis, and chronic periodontitis 
and were receiving immunosuppressant therapy. Quantitative real-time 
polymerase chain reaction was employed to evaluate the mRNA expression of 
RANKL and osteoprotegerin in these tissues. Their results showed that 
compared with healthy individuals, patients in all periodontitis groups, but not 
those with gingivitis, exhibited stronger RANKL expression and a higher 
relative RANKL/osteoprotegerin ratio. In addition, osteoprotegerin expression 
was weaker in patients with chronic periodontitis. When patients with 
  
generalized aggressive periodontitis and chronic periodontitis were compared, 
the former exhibited stronger RANKL expression, whereas the latter exhibited 
weaker osteoprotegerin expression, and there was no difference in their 
relative ratio. When chronic periodontitis patients were compared with chronic 
periodontitis patients receiving immunosuppressant therapy, osteoprotegerin, 
but not RANKL, expression was stronger in the latter. 
Tang TH, Fitzsimmons TR, Bartold PM (2009)
73
 compared  the levels 
of the soluble receptor activator of nuclear factor kappa B ligand (sRANKL), 
osteoprotegerin (OPG) and their relative ratio in gingival crevicular fluid 
(GCF) among periodontitis patients with varying smoking histories. They 
found that RANKL, OPG and their relative ratio were not statistically 
significant among the never smokers, former smokers and current smokers. 
However, OPG was significantly reduced and subsequently the 
sRANKL:OPG ratio was significantly increased in the high pack-years group 
as compared with never smokers. They, thus concluded that an increased 
lifetime exposure to cigarette smoking above a minimum threshold suppresses 
OPG production and leads to increased sRANKL:OPG. This may partially 
explain increased bone loss in smoking-related periodontitis. 
  
The effect of external force application on the RANKL/OPG ratio 
Kanzaki H, Chiba M, Shimizu Y, Mitani H. (2002)
31
 examined how 
mechanical stress affects the osteoclastogenesis-supporting activity of PDL 
cells. PDL cells were compressed continuously and then cocultured with 
peripheral blood mononuclear cells (PBMCs) for 4 weeks. PDL cells under 
mechanical stress up-regulated osteoclastogenesis from PBMCs. Furthermore, 
the expression of RANKL mRNA and protein in PDL cells increased with 
compressive force in parallel with the change in the number of osteoclasts.  In 
addition, cyclo-oxygenase 2 (COX-2) mRNA expression was induced by 
compressive force, and indomethacin inhibited the RANKL up-regulation 
resulting from compressive force. PDL cells under compressive force 
exhibited significantly increased prostaglandin E2 (PGE2) production in 
comparison with control PDL cells. Exogenous PGE2 treatment increased 
RANKL mRNA expression in PDL cells. OPG expression remained constant 
throughout compressive force or PGE2 treatment. They concluded that 
compressive force up-regulated RANKL expression in PDL cells. 
Furthermore, RANKL up-regulation in mechanically stressed PDL cells was 
dependent on PGE2. 
Tsuji K, Uno K, Zhang GX, Tamura M (2004)
78
 studied the mRNA 
expression of osteoprotegerin (OPG), receptor activator of NF-kappa B ligand 
(RANKL), tissue inhibitor of matrix metalloprotease (TIMP)-1 and -2, and 
matrix metalloprotease (MMP)-1 and -2 by human periodontal ligament 
  
(PDL) cells under intermittent tensile stress using a Flexercell Strain Unit. 
Analysis by reverse transcriptase-polymerase chain reaction showed that 
mechanical force upregulated OPG mRNA. They also demonstrated that the 
protein concentration of OPG in conditioned medium increased upon loading 
with tensile stress, as determined by enzyme-linked immunosorbent assay. 
TIMP-1 and -2 mRNA levels also increased, whereas levels of RANKL, 
MMP-1, and MMP-2 mRNA were barely affected. We further examined the 
effect of loading with tensile stress and addition of Salmonella abortus equi 
lipopolysaccharide (LPS) on the mRNA expression of PDL cells. The amount 
of OPG mRNA induced by mechanical strain was found to decrease with the 
addition of LPS to cultures. The induction of OPG mRNA expression by 
stretching was inhibited in the presence of indomethacin or genistein, whereas 
TIMP-1 mRNA expression induced by stretching was inhibited by the addition 
of cycloheximide, suggesting that tensile stress regulates cyclooxygenase 
activities, tyrosine phosphorylation, and de novo protein synthesis in PDL 
cells through the induction of OPG and TIMP-1 mRNA expression. These 
results provide evidence that the mechanical stimulus of stretching is 
responsible for the observed regulation of bone resorption and tissue 
degradation in PDL tissue. 
Ogasawara T, Yoshimine Y, Kiyoshima T, Kobayashi I, Matsuo K, 
Akamine A, Sakai H. (2004)
51
 suggested that an autocrine mechanism of 
RANKL-RANK exists in osteoclast, which is heightened in the pathological 
  
conditions. They examined the in situ expression of receptor activator of 
nuclear factor-kappaB ligand (RANKL), receptor activator of nuclear factor-
kappaB (RANK), osteoprotegerin, interleukin-1beta (IL-1beta) and tumor 
necrosis factor alpha (TNFalpha) in the osteoclasts of rat periodontal tissue. 
Four-week-old Wistar rats were used. Tooth movement was performed by the 
Waldo method, and the pathological bone resorption was induced. The 
demineralized maxillae and mandiblae were embedded with paraffin. In situ 
hybridization was performed to detect RANKL, RANK, osteoprotegerin, IL-
1beta, and TNFalpha mRNAs in osteoclasts and other cells using the specific 
RNA probes, respectively. Both RANKL and RANK were concomitantly 
expressed in some osteoclasts. RANKL was also positive in osteoblasts and 
PDLs. No IL-1beta- and TNFalpha-positive osteoclast was noted. The positive 
signals of osteoprotegerin were detected in almost all osteoblasts, PDLs and 
odontoblasts. No osteoprotegerin-positive osteoclasts were observed. The 
number and the distribution pattern of RANKL- and RANK-expressing 
osteoclasts changed when orthodontic excessive force was applied to 
periodontal tissue. In addition, IL-1beta and TNFalpha were shown to be 
expressed in osteoclasts under pathological status. They inferred that an 
autocrine mechanism of RANKL-RANK exists in osteoclast, which is 
heightened in the pathological conditions. Furthermore, the autocrine 
mechanism of IL-1beta and TNFalpha is also provided in osteoclast under 
pathological condition. These autocrine mechanisms therefore seem to 
regulate the osteoclast function in both physiological and pathological 
conditions. 
  
Yamamoto T, Kita M, Kimura I, Oseko F, Terauchi R, Takahashi K, 
Kubo T, Kanamura N (2006)
85
 investigated the effect of mechanical stress as 
hydrostatic pressure (HP) on cytokine expression in human PDL cells. The 
hPDL cells were obtained from a healthy maxillary third molar. After the third 
to fourth passage, the cells were exposed to HP ranging from 1 to 6 MPa. 
Total RNA was extracted and the expression of cytokine mRNA was 
determined by RT-PCR. The exposure to 6 MPa of HP caused no 
morphological changes of hPDL cells, and did not affect the cellular viability. 
No expression of IL-1beta, IL-6, IL-8, TNF-alpha, receptor activator of NF-
lambdaB (RANK), receptor activator of NF-lambdaB ligand (RANKL), or 
osteoprotegerin mRNA was observed in the control cells under atmospheric 
pressure, whereas, in hPDL cells treated with HP, a pressure-dependent 
enhancement of IL-6, IL-8, RANKL, and OPG mRNA expression was 
observed between 10 and 60 min after the exposure to HP. These results 
suggest that hPDL cells may play a role in the production of cytokines in 
response to mechanical stress in vivo. 
H. Kanzaki, M. Chiba, A. Sato, A. Miyagawa, K. Arai, S. Nukatsuka, 
and H. Mitani (2006)
24
 subjected a conditioned media of PDL cells to cyclical 
tensile force. They demonstrated that cyclical tensile force up-regulated not 
only RANKL mRNA expression, but also OPG mRNA expression in PDL 
cells. Tensile force up-regulated TGF-beta expression in PDL cells as well. 
Administration of neutralizing antibodies to TGF-beta inhibited OPG 
  
upregulation under cyclical tensile-force stimulation in a dose-dependent 
manner. Additionally, the osteoclastogenesis-inhibitory effect of the 
conditioned media of PDL cells under cyclical tensile force was partially 
rescued by the administration of TGF-beta neutralizing antibodies. They 
concluded that tensile force inhibited the osteoclastogenesis-supporting 
activity of PDL cells by inducing the up-regulation of OPG via TGF-beta 
stimulation. 
Tatsumi S, Ishii K, Amizuka N, Li M, Kobayashi T, Kohno K, Ito M, 
Takeshita S, Ikeda K (2007)
74
 suggested that at least in response to 
mechanical forces, osteocytes regulate the recruitment of osteoclasts to sites of 
bone resorption by inducing the expression of RANKL by osteoblastic cells in 
the local micro-environment. 
Nakajima R, Yamaguchi M, Kojima T, Takano M, Kasai K (2008)
48
 
applied a compression force of 0.5-4.0 g/cm2 to human periodontal ligament 
cells for 0-24 h and the amounts of soluble RANKL (sRANKL) and fibroblast 
growth factor-2 were measured using an enzyme-linked immunosorbent assay. 
They found that the applied compression force induced higher levels of 
sRANKL and fibroblast growth factor-2 in both a time- and magnitude-




 Kook SH, Son YO, Choe Y, Kim JH, Jeon YM, Heo JS, Kim JG,  
Lee JC (2009)
37
 examined how mechanical force affects the nature of human 
gingival fibroblasts to produce osteoprotegerin and inhibit osteoclastogenesis. 
Human gingival fibroblasts were exposed to mechanical force by 
centrifugation for 90 min at a magnitude of approximately 50 g/cm(2). The 
levels of osteoprotegerin, receptor activator of nuclear factor-kappaB ligand 
(RANKL), interleukin-1beta and tumor necrosis factor-alpha were measured 
at various time-points after applying the force. Centrifugal force stimulated the 
expression of osteoprotegerin, RANKL, interleukin-1beta and tumor necrosis 
factor-alpha by the cells, and produced a relatively high osteoprotegerin to 
RANKL ratio at the protein level. Both interleukin-1beta and tumor necrosis 
factor-alpha accelerated the force-induced production of osteoprotegerin, 
which was inhibited significantly by the addition of anti-(interleukin-1beta) 
immunoglobulin Ig isotype; IgG (rabbit polyclonal). However, the addition of 
anti-(tumor necrosis factor-alpha) immunoglobulin Ig isotype; IgG1 (mouse 
monoclonal) had no effect. Centrifugal force also had an inhibitory effect on 
osteoclast formation. They concluded that application of centrifugal force to 
human gingival fibroblasts accelerates osteoprotegerin production by these 
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 Shimizu, Noriyoshi, Maeno, 
Masao (2010)
61
 examined the effect of compressive force on the production of 
PGE2, cyclooxygenase-2 (COX-2), macrophage colony-stimulating factor (M-
CSF), receptor activator of NF-êB ligand (RANKL), and osteoprotegerin 
(OPG) using osteoblastic MC3T3-E1 cells. They found that as the 
compressive force increased, PGE2 production and the expression of COX-2, 
M-CSF, and RANKL increased, whereas OPG expression decreased. 
Celecoxib, a specific inhibitor of COX-2, blocked the stimulatory effect of CF 
on TRAP staining and the production of PGE2, M-CSF, RANKL, and OPG. 
Zhang F, Wang CL, Koyama Y, Mitsui N, Shionome C, Sanuki 
R, Suzuki N, Mayahara K, Shimizu N, Maeno M. (2010)
89
 evaluated the 
effects of compressive force during orthodontic tooth movement on cytokines 
released from periodontal ligament fibroblasts. Their results indicate that 
compressive force induces the expression of IL-17s and their receptors in 
osteoblast-like cells and that IL-17s and their receptors produced in response 
to compressive force may affect osteoclastogenesis through the expression of 




The involvement of RANKL and OPG in bone remodeling during 
orthodontic tooth movement 
Eva Low, Hans Zoellner, Om Prakash Kharbanda, and M. Ali 
Darendeliler (2005)
14
 showed by densitometric analysis that  an increase in 
background levels of OPG mRNA was evident in bony tissues subjected to 
orthodontic forces. RANKL and OPG levels were seen to increase in the 
environment during root resorption with the application of heavy forces. They 
might play a significant role during root resorption processes after orthodontic 
tooth movement. 
Y Nishijima, M Yamaguchi, T Kojima, N Aihara, R Nakajima, K 
Kasai (2006)
50
 conducted a study to determine the levels of the receptor 
activator of NFkB ligand (RANKL) and osteoprotegerin (OPG) in the gingival 
crevicular fluid (GCF) during orthodontic tooth movement and to investigate 
the effect of compression force on RANKL and OPG production from human 
periodontal ligament (hPDL) cells. Enzyme-linked immunosorbent assay 
(ELISA) kits were used to determine RANKL and OPG levels in the GCF 
collected at the distal cervical margins of the experimental and control teeth 0, 
1, 24, and 168 h after the retracting force was applied. GCF levels of RANKL 
were significantly higher, and the levels of OPG significantly lower, in the 
experimental canines than in the control teeth at 24 h, but there were no such 
significant differences at 0, 1, or 168 h. In vitro study indicated that the 
compression force significantly increased the secretion of RANKL and 
  
decreased that of OPG in hPDL cells in a time and force magnitude-dependent 
manner. The compression stimulated secretion of RANKL increased 
approximately 16.7-fold and that of OPG decreased 2.9-fold, as compared 
with the control. 
Kawasaki K, Takahashi T, Yamaguchi M, Kasai K (2006)
33
 compared 
the levels of the receptor activator of NFkB ligand (RANKL) and 
osteoprotegerin (OPG) in the gingival crevicular fluid (GCF) during 
orthodontic tooth movement in juvenile and adult patients. GCF was collected 
from the distal cervical margins of the experimental and control teeth at 0, 1, 
24, and 168 h after application of a retracting force. Enzyme-linked 
immunosorbent assay kits were used to determine RANKL and OPG levels in 
the GCF samples. The amount of tooth movement for juveniles was larger 
than for adults after 168 h. Further, after 24 h RANKL levels were increased 
and those of OPG decreased in GCF samples from the compression side 
during orthodontic tooth movement in both juveniles and adults. The 
RANKL/OPG ratio in GCF from adult patients was lower than that in the 
juvenile patient samples. Their results suggest that the age-related decrease in 
amount of tooth movement may be related to a decrease in RANKL/OPG ratio 
in GCF during the early stages of orthodontic tooth movement. 
Nakao K, Goto T, Gunjigake KK, Konoo T, Kobayashi S, Yamaguchi 
K (2007)
49
 effectively demonstrated that intermittent force induces high 
RANKL expression in human periodontal ligament cells. They examined the 
  
molecular mechanism in human periodontal ligament (PDL) cells stimulated 
by an intermittent force. PDL cells were subjected to compressive force (2.0 or 
5.0 g/cm(2)) for 2-4 days. Continuous or intermittent force was applied all day 
or for 8 hrs per day, respectively. At days 3 and 4, cell damage was less with 
intermittent force than with continuous force. At day 4, RANKL and IL-1beta 
expressions were greater with intermittent force than with continuous force. 
An IL-1 receptor antagonist inhibited the compressive force-induced RANKL 
expression. These findings indicate that IL-1beta is an autocrine factor 
regulating compressive force-induced RANKL expression in PDL cells, and 
that intermittent force can effectively induce RANKL in PDL cells with less 
cell damage. 
Matthew D. Dunn, Chan Ho Park, Paul J. Kostenuik, Sunil Kapila, 
and William V. Giannobile (2007)
44
 examined the role of OPG in regulating 
mechanically induced bone modeling in a rat model of orthodontic tooth 
movement. The maxillary first molars of male Sprague-Dawley rats were 
moved mesially using a calibrated nickel–titanium spring attached to the 
maxillary incisor teeth. Two different doses (0.5 mg/kg, 5.0 mg/kg) of a 
recombinant fusion protein (OPG-Fc), were injected twice weekly mesial to 
the first molars. Tooth movement was measured using stone casts that were 
scanned and magnified. Changes in bone quantity were measured using micro-
computed tomography and histomorphometric analysis was used to quantify 
osteoclasts and volumetric parameters. The 5.0 mg/kg OPG-Fc dose showed a 
  
potent reduction in mesial molar movement and osteoclast numbers compared 
to controls (p<0.01). The molar movement was inhibited by 45.7%, 70.6%, 
and 78.7% compared to controls at days 7, 14, and 21 respectively, with the 
high dose of OPG. The 0.5 mg dose also significantly (p<0.05) inhibited molar 
movement at days 7 (43.8%) and 14 (31.8%). The 5.0 mg/kg OPG-Fc dose 
showed a potent reduction in mesial molar movement and osteoclast numbers 
compared to controls (p<0.01). The molar movement was inhibited by 45.7%, 
70.6%, and 78.7% compared to controls at days 7, 14, and 21 respectively, 
with the high dose of OPG. The 0.5 mg dose also significantly (p<0.05) 
inhibited molar movement at days 7 (43.8%) and 14 (31.8%). They concluded 
that local delivery of OPG-Fc inhibits osteoclastogenesis and tooth movement 
at targeted dental sites. 
Hilal Uslu Toygar; Beyza Hancioglu Kircelli; Sule Bulut; Nurzen 
Sezgin; Bahar Tasdelen (2008)
26
 investigated the level of osteoprotegerin 
(OPG) in gingival crevicular fluid (GCF) during tooth movement. Twelve 
patients (13–17 years of age) requiring canine distalization participated in the 
study. GCF sampling was done at baseline, 1 hour, 24 hours, 168 hours, 1 
month, and 3 months from the distal sites of the test and with control teeth 
after the application of mechanical stress. OPG concentration was detected by 
enzyme-linked immunosorbent assay. OPG concentrations in distal sites of the 
test teeth were decreased in a time-dependent manner. The decrease is 
significant when compared with the baseline measurements (P < 0.038). 
  
Variability was detected in the levels of OPG concentration in the distal sites 
of the control tooth throughout the experimental period. They concluded that 
OPG is one of the key mediators responsible for alveolar bone remodeling 
during tooth movement. 
Fujita S, Yamaguchi M, Utsunomiya T, Yamamoto H, Kasai K. 
(2008)
18
 examined the effects of low-energy laser irradiation on expressions of 
RANK, RANKL, and OPG during experimental tooth movement.  To induce 
experimental tooth movement in rats, 10 g of orthodontic force was applied to 
the molars. Next, a Ga-Al-As diode laser was used to irradiate the area around 
the moved tooth and the amount of tooth movement was measured for 7 days. 
Immunohistochemical staining with RANK, RANKL, and OPG was 
performed. Real time PCR was also performed to elucidate the expression of 
RANK in irradiated rat osteoclast precursor cells in vitro. They found that in 
the irradiation group, the amount of tooth movement was significantly greater 
than in the non-irradiation group by the end of the experimental period. Cells 
that showed positive immunoreactions to the primary antibodies of RANKL 
and RANK were significantly increased in the irradiation group on day 2 and 
3, compared with the non-irradiation group. In contrast, the expression of OPG 
was not changed. Further, RANK expression in osteoclast precursor cells was 
detected at an early stage (day 2 and 3) in the irradiation group. 
 
  
Garlet TP, Coelho U, Repeke CE, Silva JS, Cunha Fde Q, Garlet GP 
(2008)
84
 investigated the pattern of mRNAs expression encoding for 
osteoblast and osteoclast related chemokines, and further correlated them with 
the profile of bone remodeling markers in palatal and buccal sides of tooth 
under orthodontic force, where tensile (T) and compressive (C) forces, 
respectively, predominate. Real-time PCR was performed with periodontal 
ligament mRNA from samples of T and C sides of human teeth submitted to 
rapid maxillary expansion, while periodontal ligament of normal teeth were 
used as controls. Results showed that both T and C sides exhibited significant 
higher expression of all targets when compared to controls. Comparing C and 
T sides, C side exhibited higher expression of MCP-1/CCL2, MIP-
1alpha/CCL3 and RANKL, while T side presented higher expression of OCN. 
The expression of RANTES/CCL5 and SDF-1/CXCL12 was similar in C and 
T sides. Their data demonstrate a differential expression of chemokines in 
compressed and stretched PDL during orthodontic tooth movement, 
suggesting that chemokines pattern may contribute to the differential bone 
remodeling in response to orthodontic force through the establishment of 
distinct microenvironments in compression and tension sides. 
Yamaguchi (2009)
84
 found that concentrations of RANKL in GCF 
increased during orthodontic tooth movement, and the ratio of concentration 
of RANKL to that of OPG in the GCF was significantly higher than in control 
sites. The study has shown the presence of RANKL and RANK in periodontal 
  
tissues during experimental tooth movement of rat molars, and that PDL cells 
under mechanical stress may induce osteoclastogenesis through upregulation 
of RANKL expression during orthodontic tooth movement.  
Lijun Tan; Yijin Ren; Jun Wang; Lingyong Jiang; Hui Cheng; 
Andrew Sandham; Zhihe Zhao (2009)
39
 tested the null hypothesis that 
increased tooth displacement in ovariectomized rats is not related to 
differential expressions of OPG and RANKL in the periodontium. Eighty-four 
12-week female rats were used; half were ovariectomized and half were not. 
Three months later, the maxillary first molar was moved mesially. Groups of 
rats were sacrificed at days 0, 1, 3, 5, 7, 10, and 14 after activation. Tooth 
movement was measured at each time point. OPG and RANKL expressions 
were examined through immunohistochemistry. Ovariectomized and 
nonovariectomized rats showed three-phase tooth movement. In both groups, 
OPG expression increased at the tension area and RANKL increased at the 
pressure area. The OPG/RANKL ratio coincided with tooth movement, 
especially in the linear phase from 7 to 14 days. They concluded that the 
increased rate of tooth movement in ovariectomized rats was related to 
differential expressions of OPG and RANKL. 
Patricia Joyce Brooks; Dorrin Nilforoushan; Morris Frank 
Manolson; Craig A. Simmons; Siew-Ging Gong (2009)
56
 employed a rat 
model of early orthodontic tooth movement using a split-mouth design (where 
contralateral side serves as a control) and performed immunohistochemical 
  
staining to map the spatial expression patterns of RANKL at 3 and 24 hours 
after appliance insertion. They observed increased expression of RANKL, a 
molecule associated with osteoclastic differentiation, in the compression sites 
of the periodontal ligament subjected to 3 hours of force. The early RANKL 
expression indicates that at this early stage cells are involved in osteoclast 
precursor signaling. 
Joanna Tyrovola, Despoina Perea, Dimitrios Halazonetis, Ismene 
Dontas, Ionnis Vlachos, Margarita Makou (2010)
30
 carried out a study to 
determine the levels of OPG and soluble RANKL in blood serum and GCF 
relative to the degree of orthodontic root resorption in a rat model. They 
demonstrated a positive linear correlation between the initial concentration of 
RANKL in the blood serum and the degree of root resorption. The ratio of the 
initial concentrations of OPG to RANKL in the blood serum proved to be an 
independent prognostic factor of the degree of root resorption. The 
concentration of OPG in blood serum decreased significantly in cases of 






















MATERIALS AND METHODS 
Informed consent was obtained from all the subjects and the study 
protocol was reviewed by the Institutional Review Board (IRB) of Ragas 
Dental College and Hospital, Chennai. 
The study group consisted of 10 subjects with the following inclusion criteria: 
1. All of them were treated by post-graduate students in the Department of 
Orthodontics, Ragas Dental College and Hospital, Chennai.  
2. These subjects, 4 females and 6 males ranged in age from 15 yrs to 25 
yrs. 
3. All the patients were treated using .022 Roth Ovation fully programmed 
brackets. 
4. All the subjects were indicated for upper and lower first bicuspid 
extraction. 
5. Space closure in these patients was carried out using sliding mechanics. 
6. All subjects were in good general health with healthy periodontal 
tissues. 
7. Probing depths were < 3mm with no radiographic evidence of 




Subjects were excluded if: 
1. They had antibiotic therapy during the previous six months; or 
2. They had taken anti-inflammatory medication during the month preceding 
the start of the study. 
METHODS 
Gingival crevicular fluid was collected at the following stages: 
T1 - End of Stage I-Leveling and aligning. 
T2 - Three weeks after initiation of Stage II- Space closure. 
The samples were collected at T1 and T2, from the anterior sextants of the 
maxillary and mandibular arches, amounting to a total of 4 samples per subject. 
At the beginning of Stage I, all the subjects were bonded with fully 
programmed .022 Roth Ovation brackets following upper and lower first 
bicuspid extraction. 
Leveling and aligning was carried out through a sequence of arch wires 
beginning with .014 Niti and culminating in .019 x .025 SS.  
Stage I was completed on an average within 6-8 months. 
Samples were collected at this point from the anterior sextants of both 
the arches and were labeled as T1 (Figure 3). 
  
Stage II-Space closure, was initiated using sliding mechanics. Hooks 
were soldered distal to the lateral incisors on the .019x.025 SS archwires. The 
six anterior teeth were consolidated using .008 inch SS ligature wire. 
Retraction force was applied with elastic ties. With the help of a Dontrix 
gauge (ETM Corporation, Glendora CA, USA) (Figure 5), the force was 
standardized at 300 gms per side.   
Retraction was carried out for 21 days, following which another 
sample was collected from both the arches and labeled as T2 (Figure 6). 
GCF collection 
 To avoid contamination of the GCF samples, small deposits of plaque 
were removed with a periodontal probe, and heavy deposits with a 
sickle scaler. 
 Following the isolation and drying of a site, disposable micropipettes 
(Ringcaps® -Hirschmann Labergerate, Hauptstr) (Figure 1) were 
inserted into the entrance of the gingival crevice. 
 4-5µl of GCF was collected from the six anterior teeth in both the 
maxillary and mandibular arches (Figure 4a, 4b). 
 The collected GCF was stored in sterile Eppendorf tubes (Figure 2) 
at -65°C. 
 The collected samples were analysed at Hubert Enviro Care Pvt. Ltd. 
Chennai 
  
ELISA Testing for RANKL 
The collected GCF samples were tested for RANKL using the 
RayBio® Human RANKL ELISA kit (Ray Biotech,Inc. Norcross, GA) (Figure 7). 
The microtiter plate provided in this kit has been pre-coated with an antibody 
specific to RANKL.  
Assay Procedure 
1. Each of the collected samples was diluted using the sample diluents 
provided in the kit. 
2. 100μl of sample was added per well. The wells were covered with 
adhesive strips and incubated for 2 hours at 37°C.  
3. The liquid from each well was removed, not washed.  
4. 100μl of Biotin-antibody working solution was added to each well 
and incubated for 1 hour at 37°C.  
5. Each well was aspirated and washed, repeating the process three 
times for a total of three washes. 
6. 100μl of HRP (Horseradish Peroxidase) -avidin working solution 
was added to each well and the microtiter plate was covered with a 
new adhesive strip. It was then incubated for 1 hour at 37°C.  
7. Each well was again aspirated and washed, repeating the process 
three times for a total of three washes. 
  
8. 90μl of TMB (3,3',5,5' tetramethyl-benzidine) substrate was then 
added to each well and incubated for 10-30 minutes at 37°C.  
9.  50μl of Stop Solution was then added to each well. The enzyme-
substrate reaction is terminated by the addition of the sulphuric acid 
stop solution and the color change is measured spectrophotometrically 
at a wavelength of 450 nm ± 2 nm using an ELISA plate reader 
(Figure 9). 
ELISA Testing for OPG 
The collected GCF samples were tested for RANKL using the 
RayBio® Human OPG ELISA kit (Ray Biotech,Inc. Norcross,GA) (Figure 8). 
The microtiter plate provided in this kit has been pre-coated with an antibody 
specific to OPG.  
Assay Procedure 
1. Each of the collected samples was diluted using the sample diluents 
provided in the kit. 
2. 100μl of sample was added per well. The wells were covered with 
adhesive strips and incubated for 2.5 hours at 37°C.  
3. The liquid from each well was removed, not washed.  
  
4.  100 μl of prepared biotinylated antibody was added to each well. 
The microtiter plate was then incubated for 1 hour at room 
temperature with gentle shaking. 
5. Each well was aspirated and washed, repeating the process three 
times for a total of three washes. 
6. 100 μl of prepared Streptavidin solution was added to each well and 
again incubated for 45 minutes at room temperature with gentle 
shaking. 
7. Each well was again aspirated and washed, repeating the process 
three times for a total of three washes. 
8.  100 μl of TMB One-Step Substrate Reagent was then added to each 
well. The plate was then incubated for 30 minutes at room 
temperature in the dark with gentle shaking. A blue color develops in 
proportion to the amount of Osteoprotegerin bound. 
9. 50 μl of Stop Solution was added to each well. The Stop Solution 
changes the color from blue to yellow, and the intensity of the color 





10. FIGURE 1: MICROPIPETTE FOR GCF COLLECTION 
 
 
11. FIGURE 2: EPPENDORF TUBES 
 
  








13. FIGURE 4a: GCF COLLECTION (UPPER ARCH) 
 
 




                 FIGURE 5: DONTRIX GAUGE 
 
  
FIGURE 6: THREE WEEKS AFTER INITIATION OF             
SPACE CLOSURE (T2) 
 











        FIGURE 7: HUMAN RANKL ELISA KIT 
 
 




























The optical density of the samples was determined using an ELISA plate 
reader (Figure 9). The concentration of RANKL and OPG (pg/ml) in the 
samples was then determined by comparing the optical density of the samples 
to standard curves. Linear regression analyses were employed to obtain the 
standard curves (Figure 10) from which the corresponding concentrations of 
RANKL and OPG were determined. 
 A student‘s T- Test was performed. The hypothesis being tested was 
that the concentration of RANKL in the GCF increases on 
application of retraction force and the concentration of OPG 
decreases with a concomitant increase in the RANKL/OPG ratio. 
 The statistical analysis was carried out in the following parts;  
o Mean RANKL and OPG levels in the upper arch 
o Mean RANKL and OPG levels in the lower arch 
o RANKL/OPG ratio in the Upper and Lower arches 
 The level of statistical significance was set at p=0.05.  
 If the value of ‗p‘ > 0.05, then the inference is that there is no 
statistical difference between the variables being compared.  
 However, if the value of ‗p‘ < 0.05, then the inference is that there is 




 The mean RANKL value at T1 was 1520 + 247.3 pg/ml and at T2 it 
was 1960 + 285 pg/ml. 
 A statistically significant increase (p < 0.001) in the RANKL 
concentration was observed at T2 compared to T1. (Table 1, Figure 11) 
 The mean OPG value at T1 was 42.8 + 8.3 pg/ml and at T2 it was 
29.6 + 8.43 pg/ml. 
 A statistically significant decrease (p < 0.0001) in the OPG 
concentration was observed at T2 compared to T1.(Table 1, Figure 13) 
 A statistically significant increase in the RANKL/OPG ratio (p < 
0.01) was observed from T1 (35.5 : 1) to T2 (66.2 : 1).(Table 3, 
Figure 15) 
LOWER ARCH 
 The mean RANKL value at T1 was 1584 + 279.9 pg/ml and at T2 it 
was 2008 + 276.7 pg/ml.  
 A statistically significant increase (p < 0.0001) in the RANKL 
concentration was observed at T2 compared to T1. (Table 2, 
Figure12) 
 The mean OPG value at T1 was 40.35 + 7.472 pg/ml and at T2 it was 
20.10 + 7.331 pg/ml. 
 A statistically significant decrease (p < 0.0001) in the OPG 
concentration was observed at T2 compared to T1. (Table 2, Figure 14) 
  
 A statistically significant increase in the RANKL/OPG ratio (p < 











































OD: OPTICAL DENSITY 
Pg/ml: PICOGRAMS/ MILLILITRE 
  





N Std. Error T - value P - value 
RANKL 
T1 1520 10 247.3 
5.485 <0.001 
T2 1960 10 285 
OPG 
T1 42.8 10 8.3 
10.54 <0.0001 












N Std. Error T - value P - value 
RANKL 
 
T1 1584 10 279.9 
7.940 <0.0001 
T2 2008 10 276.7 
OPG 
 
T1 40.35 10 7.472 
16.2 <0.0001 
T2 20.10 10 7.331 
 
  
Table 3: RANKL/OPG ratio- Upper Arch 
 
 



















Table 4: RANKL/OPG ratio- Lower Arch 
 






















































































FIGURE 14: OPG LEVELS IN LOWER ARCH 





















































































 Often thought of as a rigid, unchanging entity, skeletal bone is actually 
the result of a dynamic process involving the secretion and resorption of the 
bone matrix. These opposing actions are carried out by two cell types — 
osteoblasts and osteoclasts, respectively — and must be kept in balance to 
maintain skeletal integrity and calcium metabolism. 
 Continuously changing functional demands require permanent 
adaption of the bone structure and microarchitecture. Wolff
83
 has observed 
this principle of functional adaptation already over 100 years ago. The process 
of where ‗form follows function‘ 83 consists of two activities, namely, bone 
formation and bone resorption. While these processes are locally separated in 
modeling 
16,17
, bone remodeling is characterized by the spatial and temporal 
coupling of bone formation by osteoblasts and bone resorption by osteoclasts 
58
. 
Osteoclasts are formed from bone-marrow-derived precursor cells in 
response to the coordinated actions of several protein factors. The study of a 
group of these proteins –RANK/RANKL/OPG has led to a better 
understanding of the bone remodeling process. 
 
In the present study, taking into account the various changes in 
proportion of RANKL and OPG that occur during tooth movement, a ratio 
  
was sought which could act as an indicator to assess the progress of tooth 
movement. A brief review of the mechanism of action of these cytokines at the 
cellular level which is necessary to understand how the change in the 
proportions occur, is discussed here. 
RANKL exists as a homotrimeric protein and is typically membrane-
bound on osteoblastic and activated T cells or is secreted by some other cells, 
such as fibroblasts or synovial mesenchymal cells. 
34,76
 Most of the factors 
known to stimulate osteoclast formation and activity induce RANKL 
expression by osteoblastic stromal cells. It is expressed by synovial cells and 
activated T cells in joints of patients with inflammatory arthritis to contribute 
at least in part to the joint destruction seen in patients with rheumatoid 
arthritis. RANKL also stimulates the release of osteoclast precursor cells 
(OCPs) into the circulation; and recent studies suggest that osteoclasts 
themselves regulate the emergence of hematopoietic stem cells (HSCs) from 
niches within the marrow under the control of RANKL.
76 
RANK is a homotrimeric transmembrane protein member of the TNF 
receptor superfamily. It appears to be expressed in fewer tissues than RANKL 
at the protein level, but in addition to OCPs, mature osteoclasts and dendritic 
cells, it is expressed in mammary glands and some cancer cells, including 
breast and prostate cancers
38
, two tumors with high bone metastatic potential. 
Simonet et al.
66
 discovered a protein which exposed an osteopetrotic 
phenotype when overexpressed in transgenic mice. Investigating further, they 
  
found that this protein was secreted by preosteoblasts/stromal cells and was 
capable of inhibiting osteoclast development and activation. Due to its bone-
protective effects they named it osteoprotegerin. OPG belongs to the TNF 
receptor superfamily. It is expressed in a variety of tissues, including lung, 
heart, kidney, liver, stomach, intestine, brain, spinal cord, thyroid gland, 
smooth muscle tissue and bone, indicating multiple possible functions 
including endothelial cell survival
11,43
 and vascular calcification
2
. The most 
prominent role of OPG however, has been assigned to bone protection as OPG 
acts as scavenger of RANKL, thus inhibiting OC-precursors to become mature 
OC.
27 
When RANKL expression is enhanced relative to OPG, RANKL is 
available to bind with RANK on osteoclast precursors, tipping the balance to 
favor activation of osteoclast formation and bone resorption.
8
 The binding of 
RANKL to osteoclast precursors occurs at a stage when hematopoetic stem 
cells have differentiated from the colony forming unit for granulocytes and 
macrophages (CFU-GM) to the colony forming unit for macrophages (CFU-
M). Binding of RANKL to RANK on CFU-M in the presence of macrophage 
colony-stimulating factor induces differentiation of the preosteoclast into a 
multinucleated cell that becomes a mature osteoclast. 
3
 
When OPG concentrations are high relative to RANKL expression, 
OPG binds RANKL, inhibiting it from binding to RANK.
8
 Preventing the 
  
binding of RANKL to RANK leads to reduced formation of osteoclasts and 
apoptosis of existing osteoclasts.
8
 
A dynamic interaction also exists between the immune system and 
bone. Aaron and Choi
1
 coined the term ―osteoimmunology‖ and highlighted 
the interdigitate communication between the immune and skeletal systems 
especially observed in autoimmune and other inflammatory diseases. During 
inflammation, activated T cells express more of the RANKL protein and 
secrete the interferon-  molecule. RANKL is important for communication 
between T cells and antigen presenting dendritic cells. It is also essential for 
the differentiation, activation and survival of osteoclasts. It binds to RANK on 
osteoclasts to trigger intracellular signaling pathways that promote osteoclast 
differentiation and bone resorption. The TRAF6 protein is a key intermediate 
in these pathways.
1
 However, if osteoclasts were activated every time T cells 
were activated, bone loss would be more common than it is. Takayanagi et 
al.
71
 proposed a solution: interferon-  promotes the degradation of TRAF6, 
thereby preventing activated T cells from triggering massive bone destruction 
during inflammation. The effects of RANKL can also be blocked by OPG
27
, 
which is the known soluble decoy receptor. Together, then, RANKL, 
interferon-  and OPG maintain the balance between bone deposition and bone 
resorption.  
Microbial biofilms elicit a host-inflammatory process whereby 
monocytes, macrophages and neutrophils release enzymes and cytokines such 
  
as RANKL and OPG that activate osteoclasts and osteoblasts to stimulate 
bone remodeling. External mechanical stresses have also been shown to 
induce the expression of these cytokines.
31,51,85
 These proteins then traverse 
the tissue and exit through the periodontal pocket and can be measured in the 
gingival crevice fluid. 
In the present study, we found increased levels of RANKL and 
decreased levels of OPG in GCF samples collected from areas adjacent to 
teeth undergoing orthodontic tooth movement. In both the upper and lower 
arches the increase in RANKL levels and the decrease in OPG concentration 
was found to be statistically significant. (Table 1, 2) 
The RANKL levels in the upper arch increased from 1520 pg/ml at T1 
to 1960 pg/ml at T2, (p<0.001) and in the lower arch an increase from 1584 
pg/ml at T1 to 2008 pg/ml at T2 (p<0.0001) was observed. (Figure 11, 12) 
The OPG levels showed a corresponding decrease in concentration 
with the upper arch levels going from 42.8 pg/ml at T1 to 29.6 pg/ml at T2 
(p<0.0001). Similarly in the lower arch as well OPG levels declined from 
40.35 pg/ml at T1 to 20.10 pg/ml at T2 (p< 0.0001). (Figure 13, 14) 
These values enable us to interpret and calculate the relative 
RANKL/OPG which is a major determinant in bone remodeling during 
orthodontic tooth movement. Generally, bone resorption and formation follow 
  
a specific pattern and an analysis and quantification of the involved cytokines 
can help us to calculate the relative ratio. Formation of bone may be attributed 
to an abundance of OPG or reduced expression of RANKL, resulting in a net 
increase in OPG, also known as a decrease in the RANKL/OPG ratio. 
Conversely, a relative decrease in concentrations of OPG or increase in 
RANKL expression results in a net increase in RANKL and bone resorption, 





Bone Resorption:       RANKL  →      ↑ RANKL         or          =RANKL 
                                     OPG                   =OPG                             ↓OPG 
Bone Formation:     RANKL    →       = RANKL         or           ↓RANKL 
                                   OPG                     ↑ OPG                             = OPG 
 
Thus the relative proportion of RANKL and OPG determines whether 
RANK is activated, with increasing RANKL/OPG ratios associated with 
RANK-dependent cellular activation.
15
   Whether bone resorption or formation 
occurs depends critically on the RANKL/OPG ratio, which is a function of the 
relative expression levels of RANKL and OPG.
10 
In the present study, an increase in the RANKL/OPG ratio was 
recorded in both the arches which indicates a definite shift towards increased 
osteoclastic activity. (Table 3,4) 
  
 
RANKL/OPG ratio in Upper arch at T1:   1520  
                                                                    42.8 
RANKL/OPG ratio in Upper arch at T2:   1960  
                                                                    29.6 
RANKL/OPG ratio in Lower arch at T1:   1584  
                                                                    40.35 
RANKL/OPG ratio in Lower arch at T2:   2008  
                                                                    20.10 
 
In the upper arch the ratio of RANKL to OPG increased from 35.5 : 1 
at T1 to 66.2 : 1 at T2. (p<0.01)(Figure 15), while in the lower arch an 
increase in the ratio was observed from 39.3 : 1 at T1 to 99.1 : 1 at T2 
(p<0.001)(Figure 16). 
Available literature amply implicates an increase in the RANKL/OPG 
ratio in the progression of periodontal disease and in bone remodeling during 
orthodontic tooth literature. However, the factors contributing to this increase 





 demonstrated that levels of RANKL and OPG 
in GCF were reciprocally regulated in periodontal disease; i.e., an elevation in 
RANKL protein and a decrease in OPG were observed in the GCF of 
individuals with periodontitis compared with healthy controls. In contrast, a 
study by Lu,
39
 demonstrated that RANKL concentrations in GCF of 
= 35.5 : 1 
= 66.2 : 1 
= 39.3 : 1 
= 37.3 : 1 
  
individuals with periodontitis were increased compared to the controls, 
whereas the OPG concentration was unchanged. However, the findings of all 
three studies still showed a net increase in the RANKL/OPG ratio. 





 and with the majority of studies, wherein 
an increase RANKL levels and a decrease in OPG concentration both 
contributed to the resultant increase in the RANKL/OPG ratio.  
A few variations in the methodology of existing in vivo studies were 
incorporated into the present study.  
The experimental design of existing similar studies by Nishijima et al
50
 
and Kawasaki et al
33
 carried out force application with a power chain which 
does not provide a continuous and consistent force over the entire 
experimental period. It is known that elastomeric chains generally lose 50% to 
70% of their initial force during the first day of load application.
5
 Continuous 
force application was attributed to present a constant responsive state in the 
cell biology system in opposition to intermittent force application, which 
probably creates a fluctuating environment of cellular activity/quiescence.
29,80
 
Therefore, the experimental design in the present study comprised continuous 
force application by using e-ties that exert a relatively constant force during 
the entire experimental period of 3 weeks.. 
  
Another point of variation in the study methodology was the duration 
of force application. Complete orthodontic tooth movement because of the 
alveolar bone–remodeling process involves several phases55 over a certain 
period of time. In most of the existing in vivo studies, different mediators 
produced from the PDL cells that are responsible for the bone-remodeling 
mechanism during orthodontic tooth movement were evaluated over a 
relatively short period of time.
13,33,50,79
 A 168-hour investigation such as that 
undertaken by Nishijima et al,
50
 might present data belonging to only the first 
two phases of the process (displacement and delay phases, respectively) in 
most circumstances. However, data belonging to the acceleration or linear 
phase, in which true orthodontic tooth movement is considered to take place, 
require an observation period of at least 15-21 days. Therefore, we 
investigated the levels of OPG and RANKL in GCF over a 3 week period. 
The enzyme-substrate reaction in the ELISA test was terminated by the 
addition of a stop solution and the color change was measured 
spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration 
of RANKL (pg/ml) in the samples was then determined by comparing the 
optical density of the samples to the standard curve. Linear regression analyses 
were employed to obtain the standard curves from which the corresponding 
concentrations of RANKL and OPG were determined. 
For the RANKL assay the detection range was 125 pg/ml - 8000 
pg/ml. The standard curve concentrations used were 8000 pg/ml, 4000 pg/ml, 
  
2000 pg/ml, 1000 pg/ml, 500 pg/ml, 250 pg/ml, 125 pg/ml. For the OPG assay 
the detection range was 2.343 pg/ml – 150 pg/ml. The standard curve 
concentrations used were 2.343 pg/ml, 4.687 pg/ml, 9.375 pg/ml, 18.75 pg/ml, 
37.5 pg/ml, 75 pg/ml, 150 pg/ml. 
The detection of local concentration of OPG and RANKL in GCF and 
calculating the variation in the relative RANKL/OPG ratio with force 
application can help the orthodontist to assess the status of bone remodeling 
during tooth movement.  The OPG/RANKL ratio may change with the 
intensity of orthodontic forces. The orthodontist may use this information as a 
guide for detecting the optimum orthodontic treatment duration to avoid 
pathologic alveolar bone and root resorption and hyalinization in patients with 
bone metabolism pathologies such as hypoparathyrodism or 
hyperparathyroidism and also in patients with inflammatory conditions like 
periodontitis. At present, there may be many questions about the local 
response of the bone to the orthodontic forces. In the future, further research 

















Summary  and Conclusions 
  
                                        SUMMARY AND CONCLUSIONS 
 
 This study was undertaken to assess the change in RANKL and OPG 
levels in the GCF following the application of orthodontic force. GCF samples 
were collected from the upper and lower arches of orthodontic patients who 
had undergone upper and lower first bicuspid extractions. The samples were 
collected at two time points; T1-End of stage I (Leveling & aligning) and  
T2- Three weeks after application of retraction force. Disposable micropipettes 
were used for GCF collection and the collected samples were subjected to an 
ELISA test to determine the concentrations of RANKL and OPG. 
 Both upper and lower arches showed an increase in RANKL levels 
from T1 to T2. 
 In the upper arch a statistically significant increase (p < 0.001) in the 
RANKL concentration was observed at T2 (1960 + 285pg/ml) 
compared to T1 (1520 + 247.3pg/ml). 
 In the lower arch as well a statistically significant increase (p < 
0.0001) in the RANKL concentration was observed at T2 (2008 + 
276.7pg/ml) compared to T1 (1584 + 279.9 pg/ml) 
 
 A reciprocal decrease in the OPG concentration was observed in the 
upper and lower arches. 
  
 The upper arch showed a decrease in OPG levels from 42.8 + 8.3 
pg/ml at T1 to 29.6 + 8.43 pg/ml at T2. (p<0.0001) 
 The lower arch showed a decrease in OPG levels from 40.35 + 7.472 
pg/ml at T1 to 20.10 + 7.331 pg/ml at T2. (p<0.0001) 
 An increase in the relative RANKL/OPG ratio was seen in both 
arches.  
 In the upper arch, RANKL/OPG ratio increased from 35.5 : 1 at T1 
to 66.2 : 1 at T2. (p<0.01) 
 The lower arch showed an increase in RANKL/OPG ratio from 
39.3:1 at T1 to 99.1:1 at T2. (p<0.001) 
 Both factors, i.e, an increase in the RANKL levels and a decrease in 
the OPG levels contributed to the observed increase in RANKL/OPG 
ratio. This is in accordance with existing invivo studies by Mogi et 
al.
42
 and Bostanci et al.
46
  
 The present findings differed from a study done by Lu et al.
39
 where 
the OPG levels remained unchanged and only an increase in RANKL 
concentration contributed to the increase in RANKL/OPG ratio. 
 
 The study design varied from existing studies in the manner and 
duration of force application.  
  
 Instead of elastic chains which were used in previous studies, this 
study used e-ties to apply the retraction force. This was done to 
provide a relatively constant force over the entire experimental period. 
 Existing invivo studies have compared the cytokine levels 168 hours 
after application of orthodontic force. This study increased the 
duration of the force application to 3 weeks to obtain data belonging 
to the linear or acceleration phase of tooth movement which require 
an observation period of at least 15-21 days 
 Further research in this field would help to refine the analysis of 
these biologic markers of tooth movement in a clinical setting. This 
sort of advancement would be especially useful in patients with bone 
metabolic problems as well as in patients suffering from 
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